Recent advances in peptide-based therapy for Type 2 diabetes and obesity

J. Michael Conlon*, Peter R. Flatt, Clifford J. Bailey

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Abstract

The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.
Original languageEnglish
Article number170652
JournalPeptides
Volume145
Early online date20 Sep 2021
DOIs
Publication statusE-pub ahead of print - 20 Sep 2021

Bibliographical note

© 2021, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Fingerprint

Dive into the research topics of 'Recent advances in peptide-based therapy for Type 2 diabetes and obesity'. Together they form a unique fingerprint.

Cite this